Soleus Capital Management, L.P. Celcuity Inc. Transaction History

Soleus Capital Management, L.P.

$1.64 Billion
Q3 2025

A detailed history of Soleus Capital Management, L.P. transactions in Celcuity Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 1,178,860 shares of CELC stock, worth $109 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares

1,178,860

Previous 3,011,818 60.86%

Holding current value

$109 Million

Previous $40.2 Million 44.1%

% of portfolio

3.52%

Previous 3.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$12.58 - $62.68 $23.1 Million - $115 Million	-1,832,958 Reduced 60.86%	1,178,860 $57.9 Million
Q2 2025 Aug 14, 2025	BUY	$8.21 - $13.35 $3.59 Million - $5.84 Million	437,696 Added 17.0%	3,011,818 $40.2 Million
Q1 2025 May 15, 2025	BUY	$8.62 - $13.62 $77,881 - $123,056	9,035 Added 0.35%	2,574,122 $26 Million
Q4 2024 Feb 14, 2025	BUY	$12.0 - $16.35 $15.8 Million - $21.6 Million	1,319,700 Added 105.97%	2,565,087 $33.6 Million
Q3 2024 Nov 14, 2024	BUY	$13.98 - $19.15 $478,116 - $654,930	34,200 Added 2.82%	1,245,387 $18.6 Million

Q2 2024 Aug 14, 2024	SELL	$14.1 - $20.78 $7.33 Million - $10.8 Million	-520,151 Reduced 30.04%	1,211,187 $19.8 Million
Q1 2024 May 15, 2024	SELL	$13.74 - $21.6 $6.16 Million - $9.68 Million	-448,143 Reduced 20.56%	1,731,338 $37.4 Million
Q4 2023 Feb 14, 2024	BUY	$8.7 - $15.02 $1.07 Million - $1.85 Million	122,997 Added 5.98%	2,179,481 $31.8 Million
Q3 2023 Nov 14, 2023	BUY	$8.96 - $10.75 $1.19 Million - $1.43 Million	133,201 Added 6.93%	2,056,484 $18.8 Million
Q2 2023 Aug 14, 2023	BUY	$9.39 - $12.18 $2.21 Million - $2.87 Million	235,350 Added 13.94%	1,923,283 $21.1 Million
Q1 2023 May 15, 2023	BUY	$9.4 - $12.82 $4.49 Million - $6.12 Million	477,705 Added 39.47%	1,687,933 $17.3 Million
Q4 2022 Feb 14, 2023	BUY	$7.55 - $14.01 $5.79 Million - $10.7 Million	766,316 Added 172.63%	1,210,228 $17 Million
Q3 2022 Nov 14, 2022	BUY	$8.0 - $10.64 $200,000 - $266,000	25,000 Added 5.97%	443,912 $4.46 Million
Q2 2022 Aug 15, 2022	BUY	$5.35 - $10.11 $2.07 Million - $3.91 Million	386,839 Added 1206.12%	418,912 $3.81 Million
Q4 2021 Feb 14, 2022	SELL	$11.96 - $19.35 $617,315 - $998,750	-51,615 Reduced 61.68%	32,073 $423,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $24.87 $1.41 Million - $2.02 Million	-81,136 Reduced 49.23%	83,688 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $2.35 Million - $5.1 Million	164,824 New	164,824 $3.96 Million

Others Institutions Holding CELC

# of Institutions

186

Shares Held

38.3M

Call Options Held

574K

Put Options Held

205K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $1.38B
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. Celcuity Inc. Transaction History